3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Evidence-based protocol for safely discontinuing Vyvanse (lisdexamfetamine), including taper schedules, withdrawal symptom management, and monitoring benchmarks drawn from FDA labeling and primary literature.
What is established, plausible, and unverified about switching between Vyvanse (lisdexamfetamine) and other ADHD stimulants or non-stimulants, including dose conversion logic and a monitoring framework.
A clinical deep-dive into how lisdexamfetamine (Vyvanse) affects hair and skin, covering the mechanisms behind hair shedding, skin picking, hyperhidrosis, and pallor, with primary-literature citations and practical management guidance.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.